Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 970 | N/A | 1,190 | N/A | 1,200 |
| Marketable Securities | 3,610 | N/A | 4,210 | N/A | 3,950 |
| Receivables | 410 | N/A | 790 | N/A | 690 |
| Inventories | 1,080 | N/A | 580 | N/A | 700 |
| Other current assets | 230 | 540 | 290 | 0 | 240 |
| TOTAL | $6,300 | $540 | $7,060 | $N/A | $6,780 |
| Non-Current Assets | |||||
| PPE Net | 2,970 | 2,930 | 2,940 | N/A | 1,770 |
| Other Non-Current Assets | 691 | 460 | 400 | 0 | 1,390 |
| TOTAL | $3,661 | $3,390 | $3,340 | $N/A | $3,160 |
| Total Assets | $9,980 | $3,930 | $10,410 | $N/A | $9,950 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 140 | 100 | 110 | 0 | 80 |
| Accrued Expenses | 220 | 380 | 230 | N/A | 210 |
| Other current liabilities | 0 | 0 | 0 | N/A | 350 |
| TOTAL | $360 | $480 | $350 | $N/A | $690 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $700 |
| Total Liabilities | $360 | $480 | $350 | $N/A | $1,390 |
| Shareholders' Equity | |||||
| Common Shares | 320 | 320 | 320 | N/A | 320 |
| Retained earnings | 0 | N/A | 860 | N/A | -440 |
| Other shareholders' equity | 370 | 200 | 210 | 0 | 330 |
| TOTAL | $9,620 | $9,240 | $10,050 | $N/A | $8,550 |
| Total Liabilities And Equity | $9,980 | $9,720 | $10,400 | $0 | $9,940 |